The associations of gut microbiota, endocrine system and bone metabolism
How many treatments are required
AOD-9604's pivotal Phase 2b trial failed its primary endpoint: 536 participants, 24 weeks, no statistically significant fat loss versus placebo
HUVECs (310 4 cells per well) were seeded in top chambers with DMSO or various doses of BPC-157 (1 g/mL, 5 g/mL, and 10 g/mL) in 500 mL RPMI 1640 with 0.5% FBS
Research into IGF1 LR3s effects on aging has provided insights into the role of growth factor signaling in age-related changes
Ramos-Jimnez A, Hernndez-Torres RP, Hernndez-Ontiveros DA, Ortiz-Ortiz M, Lpez-Fregoso RJ, Martnez-Sanz JM, Rodrguez-Uribe G, Hernndez-Lepe MA